ProMIS Neurosciences Q3 EPS $(0.19) Up From $(0.85) YoY
Portfolio Pulse from Benzinga Newsdesk
ProMIS Neurosciences (NASDAQ:PMN) reported a narrower loss of $(0.19) per share in Q3, improving from a loss of $(0.85) per share in the same quarter last year, marking a 77.65% increase in earnings.
November 14, 2023 | 10:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ProMIS Neurosciences reported a significant improvement in its quarterly earnings, with a loss per share decreasing from $(0.85) to $(0.19) year-over-year.
The reported earnings show a substantial improvement compared to the previous year, which is typically viewed positively by investors and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100